NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives
Estimated value
—
Awarded value
£160.0m
Awarded 25 Feb 2026
Suppliers
2
Lots
1
1 awarded
Published
26 Feb 2026
Awarded suppliers· 2 suppliers
Awarded 25 Feb 2026 · Contract period 31 Mar 2026 — 31 Mar 2028
Award value
£160.0m